GlassScriptPhysician profile
Amrith Jamoona
NPI 1750517231
$3,461.89
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,136 · 2020: $404 · 2021: $109 · 2022: $86.05 · 2023: $386 · 2024: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $1,698.79 | 2019-2023 | Aesculap Ff399r Adaptor |
| Stryker Corporation | $811.55 | 2019-2021 | |
| Penumbra, INC. | $340.89 | 2024 | Artemis, Red 72 |
| Zimmer Biomet Holdings, INC. | $144.24 | 2023 | Neuro Plating System |
| Cerapedics INC. | $104.62 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Spineology INC. | $73.13 | 2022 | |
| Globus Medical, INC. | $58.49 | 2019 | |
| Bk Medical Holding Company INC. | $58.34 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Abbott Laboratories | $33.98 | 2019 | |
| Monteris Medical Corporation | $33.75 | 2019 | |
| Microvention, INC. | $32.42 | 2019 | |
| Si-Bone, INC. | $30.73 | 2019 | |
| Lemaitre Vascular, INC. | $29.93 | 2019-2020 | |
| Misonix INC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amrith Jamoona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.